Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 716
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06910449 Hemithoracic Arc Radiotherapy Post Pleural Decortication |
hemithoracic Volumetric Arc Radio… | Cancer | Non applicable | COMPLETED | En attente / non publié | Cairo University | Egypt · national Cancer Institute Cairo university, C… | 2024-11-11 → 2026-10-15 | Ouvrir |
| NCT05866432 TUXEDO-2 — Phase II Study of Dato-DXd in Triple-negative Breast Cancer … |
Datopotamab deruxtecan | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Medical University of Vienna | Austria · AKH Universitaetsklinikum Vienna, Departmen… | 2023-07-01 → 2027-07-01 | Ouvrir |
| NCT07173751 ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With… |
Pumitamig | Cancer | Phase 3 | RECRUITING | En attente / non publié | BioNTech SE | United States, Argentina, Australia, Belgium, Brazil,… | 2025-10-30 → 2030-09 | Ouvrir |
| NCT06499870 Relugolix and Enzalutamide in Combination With Radiation Therapy for th… |
Biopsy | Cancer | Phase 2 | RECRUITING | En attente / non publié | Mayo Clinic | United States · Northwestern University, Chicago, Uni… | 2024-09-06 → 2032-11-19 | Ouvrir |
| NCT05455697 Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard T… |
Bone marrow biopsy | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Uma Borate | United States · Fred Hutch/University of Washington C… | 2023-01-26 → 2027-01-05 | Ouvrir |
| NCT07513376 INTerpath-014 — A Clinical Trial of Adjuvant Intismeran (V940) With or … |
Intismeran | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Brazil, Canada, Chile, Colo… | 2026-05-04 → 2038-05-11 | Ouvrir |
| NCT04613596 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembroli… |
Adagrasib | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | Mirati Therapeutics Inc. | United States, Argentina, Australia, Austria, Belgium… | 2020-12-02 → 2029-10-31 | Ouvrir |
| NCT05975307 BCIRT-01 — Treating Muscle-invasive Bladder Cancer With A Non-surgical … |
Toripalimab | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sun Yat-sen University | China · Cancer Center, Sun Yat-sen University, Guangz… | 2023-12-01 → 2029-12-31 | Ouvrir |
| NCT07778979 Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliom… |
[18F]FMISO-PET with contrast-enha… | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | University of Alabama at Birmingh… | United States · UAB, Birmingham, United States | 2026-11 → 2030-11 | Ouvrir |
| NCT07907354 Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and… |
Apatinib mesylate | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Yunnan Cancer Hospital | Non communiqué | 2027-03-01 → 2030-06-30 | Ouvrir |
| NCT06487481 Study of Preoperative Radiation Therapy in Participants With Resectable… |
Surgical resection | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-11-04 → 2040-12-01 | Ouvrir |
| NCT05086692 ABILITY-1 — A Beta-only IL-2 ImmunoTherapY Study |
MDNA11 | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Medicenna Therapeutics, Inc. | United States, Australia, Canada, Ireland, Portugal, … | 2021-08-27 → 2028-10-20 | Ouvrir |
| NCT07906717 A Study of JNJ-101556143 With Best Supportive Care in Participants With… |
JNJ-101556143 | Cancer | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Janssen Research & Development, L… | Rambam Medical Center, Haifa, Israel | Renovatio Clin… | 2026-11-06 → 2028-08-18 | Ouvrir |
| NCT07570173 A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic L… |
MK-1045 | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Canada, Denmark, France, Greece, Israel, Italy, Japan… | 2026-05-18 → 2033-10-18 | Ouvrir |
| NCT06090669 Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1… |
TruSight Oncology | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2023-12-19 → 2027-10-30 | Ouvrir |
| NCT06922318 The COSMYC Trial (COmbined Suppression of MYC) |
ZEN-3694 | Cancer | Phase 2 | RECRUITING | En attente / non publié | Sidney Kimmel Comprehensive Cance… | United States · Johns Hopkins Sidney Kimmel Comprehen… | 2025-08-19 → 2031-08-30 | Ouvrir |
| NCT06991738 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodin… |
177Lu-DOTA-EB-TATE | Cancer | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | National Institute of Diabetes an… | United States · National Institutes of Health Clinica… | 2026-11-04 → 2032-08-01 | Ouvrir |
| NCT07667400 Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cel… |
SX-682 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-11-04 → 2037-10-01 | Ouvrir |
| NCT04165070 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (… |
Pembrolizumab | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Canada, Hungary, Israel, Italy, Poland… | 2019-12-19 → 2032-10-13 | Ouvrir |
| NCT07711639 FR-taVNS Tinnitus Tria |
True Foot Reflexology | SEP | Non applicable | RECRUITING | En attente / non publié | Tzu Chi University | Taiwan · Hualien Tzu Chi Hospital, Department of Otor… | 2026-04-28 → 2028-12-31 | Ouvrir |
| NCT05457556 Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Trans… |
Biospecimen Collection | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Roswell Park Cancer Institute | United States, Australia, Canada · AdventHealth Orlan… | 2023-03-15 → 2027-07-07 | Ouvrir |
| NCT04169737 Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the… |
Acalabrutinib | SEP | Phase 2 | RECRUITING | En attente / non publié | City of Hope Medical Center | United States · M D Anderson Cancer Center, Houston, … | 2020-07-29 → 2028-07-09 | Ouvrir |
| NCT02483000 Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transpla… |
Anti-CD20 B9E9 scFv-Streptavidin … | SEP | Phase 1 | TERMINATED | En attente / non publié | Fred Hutchinson Cancer Center | United States · Fred Hutch/University of Washington C… | 2017-02-01 → 2020-09-02 | Ouvrir |
| NCT07853690 Histotripsy in Biliary Tract Cancer |
Histotripsie — HistoSonics Edison… | Cancer | Non applicable | RECRUITING | En attente / non publié | Northwell Health | United States · NYU Langone Health, New York, United … | 2026-10-05 → 2028-09 | Ouvrir |
| NCT06246968 A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in … |
Histotripsie — HistoSonics Edison… | Cancer | Phase 1 | RECRUITING | En attente / non publié | Northwell Health | United States · Memorial Sloan Kettering Bergen (Limi… | 2024-01-29 → 2027-01-29 | Ouvrir |